Literature DB >> 9814474

Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate.

S P Coburn1, J D Mahuren, M Jain, Y Zubovic, J Wortsman.   

Abstract

Natural and artificial manipulation of tissue nonspecific alkaline phosphatase activity indicates that pyrophosphate, phosphoethanolamine, and pyridoxal 5'-phosphate are among the natural substrates for this enzyme. Although inorganic phosphate has been recognized as a competitive inhibitor of this enzyme for many years, the influence of phosphate on alkaline phosphatase activity in serum under physiological conditions has not been previously reported. We examined the kinetics of tissue nonspecific alkaline phosphatase from bovine kidney and sera from 49 patients with a wide range of endogenous phosphate concentrations using pyridoxine 5'-phosphate as a substrate at pH 7.4. For the bovine kidney enzyme, the Km was 0.42 +/- 0.04 micromol/L, and the Ki for phosphate was 2.4 +/- 0.2 micromol/L. Analysis of the kinetics using pyridoxine 5'-phosphate in undiluted serum from 10 subjects with phosphorus ranging from 0.5-2.1 mmol/L and alkaline phosphatase activity ranging from 41-165 nmol/min x mL gave estimates for the Km of 56 +/- 11 micromol/L and for the Ki of 540 +/- 82 micromol/L for phosphate. This indicates that under physiological conditions alkaline phosphatase activity toward pyridoxine 5'-phosphate is reduced approximately 50% by the normal phosphate concentration and that it will increase or decrease significantly in response to changes in phosphate concentration within the ranges observed clinically.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9814474     DOI: 10.1210/jcem.83.11.5288

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Direct and Functional Biomarkers of Vitamin B6 Status.

Authors:  Per Magne Ueland; Arve Ulvik; Luisa Rios-Avila; Øivind Midttun; Jesse F Gregory
Journal:  Annu Rev Nutr       Date:  2015-05-13       Impact factor: 11.848

2.  2-Benzylidenebenzofuran-3(2H)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Authors:  Jamshaid Ashraf; Ehsan Ullah Mughal; Reem I Alsantali; Amina Sadiq; Rabab S Jassas; Nafeesa Naeem; Zaman Ashraf; Yasir Nazir; Muhammad Naveed Zafar; Amara Mumtaz; Masoud Mirzaei; Satar Saberi; Saleh A Ahmed
Journal:  RSC Adv       Date:  2021-10-29       Impact factor: 4.036

3.  Plasma pyrophosphate and vascular calcification in chronic kidney disease.

Authors:  W Charles O'Neill; Mhairi K Sigrist; Christopher W McIntyre
Journal:  Nephrol Dial Transplant       Date:  2009-07-24       Impact factor: 5.992

4.  Acute hypophosphatasemia.

Authors:  F E McKiernan; L K Shrestha; R L Berg; J Fuehrer
Journal:  Osteoporos Int       Date:  2013-08-03       Impact factor: 4.507

5.  Characterization of human periodontal ligament cells cultured on three-dimensional biphasic calcium phosphate scaffolds in the presence and absence of L-ascorbic acid, dexamethasone and β-glycerophosphate in vitro.

Authors:  Shaofeng An; Yan Gao; Junqi Ling
Journal:  Exp Ther Med       Date:  2015-08-24       Impact factor: 2.447

6.  Francisella DnaK inhibits tissue-nonspecific alkaline phosphatase.

Authors:  Bernard P Arulanandam; Senthilnath Lakshmana Chetty; Jieh-Juen Yu; Sean Leonard; Karl Klose; Janakiram Seshu; Andrew Cap; James J Valdes; James P Chambers
Journal:  J Biol Chem       Date:  2012-08-24       Impact factor: 5.157

7.  Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification.

Authors:  Campbell R Sheen; Pia Kuss; Sonoko Narisawa; Manisha C Yadav; Jessica Nigro; Wei Wang; T Nicole Chhea; Eduard A Sergienko; Kapil Kapoor; Michael R Jackson; Marc F Hoylaerts; Anthony B Pinkerton; W Charles O'Neill; José Luis Millán
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

8.  The ANKH ΔE490Mutation in Calcium Pyrophosphate Dihydrate Crystal Deposition Disease (CPPDD) affects tissue non-specific Alkaline Phosphatase (TNAP) activities.

Authors:  John Wang; Hing Wo Tsui; Frank Beier; Kenneth P H Pritzker; Robert D Inman; Florence W L Tsui
Journal:  Open Rheumatol J       Date:  2008-04-10

9.  Transgenic Overexpression of Tissue-Nonspecific Alkaline Phosphatase (TNAP) in Vascular Endothelium Results in Generalized Arterial Calcification.

Authors:  Alexei Y Savinov; Maryam Salehi; Manisha C Yadav; Ilian Radichev; José Luis Millán; Olga V Savinova
Journal:  J Am Heart Assoc       Date:  2015-12-16       Impact factor: 5.501

10.  Biochemical, clinical and genetic characteristics in adults with persistent hypophosphatasaemia; Data from an endocrinological outpatient clinic in Denmark.

Authors:  Nicola Hepp; Anja Lisbeth Frederiksen; Morten Duno; Jakob Præst Holm; Niklas Rye Jørgensen; Jens-Erik Beck Jensen
Journal:  Bone Rep       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.